However, the negative impacts of STK11/LKB1 genomic alterations on resistance to ICIs are also seen in PD-L1 positive NSCLC, suggesting that PD-L1 expression is partially dependent on STK11 (123). The gene discussed is STK11; the disease is non-small cell lung carcinoma.